# Prevention of Osteoporosis in Men With Prostate Cancer

> **NCT00048841** · PHASE3 · COMPLETED · sponsor: **National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)** · enrollment: 112 (—)

## Conditions studied

- Prostate Cancer
- Osteoporosis
- Hypogonadism

## Interventions

- **DRUG:** alendronate

## Key facts

- **NCT ID:** NCT00048841
- **Lead sponsor:** National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
- **Sponsor class:** NIH
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-05
- **Primary completion:** —
- **Final completion:** 2005-12
- **Target enrollment:** 112 (—)
- **Last updated:** 2010-03-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00048841

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00048841, "Prevention of Osteoporosis in Men With Prostate Cancer". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00048841. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*